EP3810110A4 - Combinaison comprenant du fingolimod et de l'amantadine - Google Patents

Combinaison comprenant du fingolimod et de l'amantadine Download PDF

Info

Publication number: EP3810110A4
Authority: EP; European Patent Office
Prior art keywords: amantadine; combination including; fingolimod; including fingolimod; combination
Prior art date: 2018-06-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19823241.5A

Other languages

German (de)

English (en)

Other versions

EP3810110A2 (fr

Inventor

Ali Turkyilmaz

Merve PEKER

Emine TUNCAY

Erkin Ozturk

Muge ULUSOY BOZYEL

Yavuz Dedeoglu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanovel Ilac Sanayi ve Ticaret AS

Original Assignee

Sanovel Ilac Sanayi ve Ticaret AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-06-21

Filing date

2019-06-20

Publication date

2022-03-16

2019-06-20 Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS

2021-04-28 Publication of EP3810110A2 publication Critical patent/EP3810110A2/fr

2022-03-16 Publication of EP3810110A4 publication Critical patent/EP3810110A4/fr

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP19823241.5A 2018-06-21 2019-06-20 Combinaison comprenant du fingolimod et de l'amantadine Withdrawn EP3810110A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
TR201808819		2018-06-21
PCT/TR2019/050477 WO2019245513A2 (fr)	2018-06-21	2019-06-20	Combinaison comprenant du fingolimod et de l'amantadine

Publications (2)

Publication Number	Publication Date
EP3810110A2 EP3810110A2 (fr)	2021-04-28
EP3810110A4 true EP3810110A4 (fr)	2022-03-16

Family

ID=68983747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19823241.5A Withdrawn EP3810110A4 (fr)	2018-06-21	2019-06-20	Combinaison comprenant du fingolimod et de l'amantadine

Country Status (2)

Country	Link
EP (1)	EP3810110A4 (fr)
WO (1)	WO2019245513A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013055907A1 (fr) *	2011-10-12	2013-04-18	Teva Pharmaceutical Industries Ltd.	Traitement de la sclérose en plaques par combinaison de laquinimod et de fingolimod

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016064997A1 (fr) *	2014-10-22	2016-04-28	The Regents Of The University Of California	Compositions et méthodes pour le traitement de la fatigue et de la dépression
US20160228388A1 (en)	2014-11-04	2016-08-11	Adamas Pharmaceuticals, Inc.	Methods of administering amantadine compositions

2019
- 2019-06-20 EP EP19823241.5A patent/EP3810110A4/fr not_active Withdrawn
- 2019-06-20 WO PCT/TR2019/050477 patent/WO2019245513A2/fr not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013055907A1 (fr) *	2011-10-12	2013-04-18	Teva Pharmaceutical Industries Ltd.	Traitement de la sclérose en plaques par combinaison de laquinimod et de fingolimod

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALICE LARONI ET AL: "Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial", BMC NEUROLOGY, BIOMED CENTRAL LTD., LONDON, GB, vol. 14, no. 1, 1 April 2014 (2014-04-01), pages 65, XP021184467, ISSN: 1471-2377, DOI: 10.1186/1471-2377-14-65 *
JEFFREY A COHEN ET AL: "MULTIPLE SCLEROSIS MSJ JOURNAL Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo- controlled, phase 2 trial", 1 January 2018 (2018-01-01), XP055472325, Retrieved from the Internet <URL:http://journals.sagepub.com/doi/pdf/10.1177/1352458518754716> [retrieved on 20180503] *
LIMMROTH V ET AL: "Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study", BMC NEUROLOGY 20170118 BIOMED CENTRAL LTD. GBR, vol. 17, no. 1, 18 January 2017 (2017-01-18), XP009533336, ISSN: 1471-2377 *
See also references of WO2019245513A2 *

Also Published As

Publication number	Publication date
WO2019245513A3 (fr)	2020-03-19
EP3810110A2 (fr)	2021-04-28
WO2019245513A2 (fr)	2019-12-26

Legal Events

Date	Code	Title	Description
2019-12-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2021-03-26	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2021-03-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2021-04-28	17P	Request for examination filed	Effective date: 20201225
2021-04-28	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2021-04-28	AX	Request for extension of the european patent	Extension state: BA ME
2021-09-29	DAV	Request for validation of the european patent (deleted)
2021-09-29	DAX	Request for extension of the european patent (deleted)
2022-03-16	A4	Supplementary search report drawn up and despatched	Effective date: 20220215
2022-03-16	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 25/00 20060101ALI20220209BHEP Ipc: A61K 31/137 20060101ALI20220209BHEP Ipc: A61K 31/13 20060101AFI20220209BHEP
2023-01-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2023-02-22	18D	Application deemed to be withdrawn	Effective date: 20220915

Publication	Publication Date	Title
EP3735685A4 (fr)	2021-05-05	Panneau d'affichage
EP3797853A4 (fr)	2021-07-21	Purificateur d'air
EP3750149C0 (fr)	2025-04-02	Panneau d'affichage
EP3798719A4 (fr)	2021-08-11	Panneau d'affichage
EP3661363A4 (fr)	2021-07-28	Compositions d'inoculums microbiens et procédés
EP3518708A4 (fr)	2020-05-27	Structure d'assise souple
EP3816518A4 (fr)	2022-03-30	Purificateur d'air
EP3755296A4 (fr)	2021-04-07	Support d'assise
EP3982415A4 (fr)	2022-09-07	Panneau d'affichage
EP3856390A4 (fr)	2021-11-17	Purificateur d'air
JP2020012785A5 (fr)	2021-03-25
MA49822A (fr)	2020-06-17	Combinaison pharmaceutique comprenant du ponesimod
EP3794015A4 (fr)	2022-03-30	Agents d'activation
EP3886698A4 (fr)	2022-08-10	Indicateur d'haleine
EP3897798A4 (fr)	2022-09-07	Réservoir d'humidificateur
EP3742509A4 (fr)	2021-09-29	Panneau d'affichage
EP3634226A4 (fr)	2021-01-27	Détermination d'indicateur
EP3741987A4 (fr)	2021-01-13	Purificateur d'air
EP3810110A4 (fr)	2022-03-16	Combinaison comprenant du fingolimod et de l'amantadine
EP3651199A4 (fr)	2021-03-03	Panneau d'affichage
EP3589695A4 (fr)	2021-01-20	Revêtements omniphobes durcissables à l'humidité
EP3890849A4 (fr)	2022-08-24	Coussinet d'entraînement
MA51199A (fr)	2020-10-07	Agents d'imagerie
EP3796813A4 (fr)	2021-08-04	Meuble d'assise
EP3747955A4 (fr)	2021-12-22	Agent de détection d'acétylpolyamine